Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder
- PMID: 10379728
- DOI: 10.1097/00005392-199907000-00002
Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder
Abstract
Purpose: Pharmacological treatment of the overactive bladder relies on partially blocking the efferent parasympathetic innervation to the detrusor with anticholinergic drugs. However, often these drugs have troublesome side effects and doses are insufficient to restore continence in patients with detrusor instability. We present the background, basic and clinical research with intravesical instillation of capsaicin and resiniferatoxin as treatments for the overactive bladder.
Materials and methods: Capsaicin, the main pungent ingredient in hot peppers of the genus Capsicum, is a specific neurotoxin that desensitizes C fiber afferent neurons which may be responsible for signals that trigger detrusor overactivity.
Results: In the last 6 years studies have demonstrated encouraging improvement in lower urinary tract symptoms with minimal long-term complications. Most of these studies have also demonstrated that the acute pain and irritation associated with capsaicin are major deterrents to widespread use. Therefore, resiniferatoxin, an ultra-potent analogue of capsaicin which appears to have similar efficacy but less acute side effects, may be more useful.
Conclusions: Intravesical capsaicin and resiniferatoxin are novel and promising treatments for the overactive bladder, with profound basic and clinical implications.
Similar articles
-
Intravesical neuromodulatory drugs: capsaicin and resiniferatoxin to treat the overactive bladder.J Endourol. 2000 Feb;14(1):97-103. doi: 10.1089/end.2000.14.97. J Endourol. 2000. PMID: 10735579 Review.
-
Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.J Urol. 2003 Sep;170(3):835-9. doi: 10.1097/01.ju.0000081652.31524.27. J Urol. 2003. PMID: 12913711
-
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study.J Urol. 2002 Apr;167(4):1710-4. J Urol. 2002. PMID: 11912393 Clinical Trial.
-
[Intravesical instillations of capsaicin in urology: from pharmacological principles to therapeutic applications].Prog Urol. 1999 Sep;9(4):615-32. Prog Urol. 1999. PMID: 10555213 Review. French.
-
Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.J Urol. 2004 Jan;171(1):251-5. doi: 10.1097/01.ju.0000100385.93801.d4. J Urol. 2004. PMID: 14665887 Clinical Trial.
Cited by
-
Transcutaneous electrical nerve stimulation and solifenacin succinate versus solifenacin succinate alone for treatment of overactive bladder syndrome: A double-blind randomized controlled study.PLoS One. 2021 Jun 23;16(6):e0253040. doi: 10.1371/journal.pone.0253040. eCollection 2021. PLoS One. 2021. PMID: 34161360 Free PMC article. Clinical Trial.
-
Inhibitory and excitatory perigenital-to-bladder spinal reflexes in the cat.Am J Physiol Renal Physiol. 2008 Mar;294(3):F591-602. doi: 10.1152/ajprenal.00443.2007. Epub 2007 Dec 26. Am J Physiol Renal Physiol. 2008. PMID: 18160624 Free PMC article.
-
Urothelial signaling.Physiol Rev. 2013 Apr;93(2):653-80. doi: 10.1152/physrev.00030.2012. Physiol Rev. 2013. PMID: 23589830 Free PMC article. Review.
-
[100 years urology in Germany. Neuro-urology].Urologe A. 2006 Sep;45 Suppl 4:195-202. doi: 10.1007/s00120-006-1141-4. Urologe A. 2006. PMID: 16858604 German. No abstract available.
-
Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome.ISRN Pharmacol. 2014 Jan 15;2014:601653. doi: 10.1155/2014/601653. eCollection 2014. ISRN Pharmacol. 2014. PMID: 24527221 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical